A note from Augmedix about COVID-19

Augmedix Updates

Augmedix Announces Additional $19 Million in Series B Funding

Major investors, including Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments and others supplied fresh funding to accelerate scaling of Augmedix and to deepen the company's leading note automation technology.

Read More

Internal Updates
Other Updates